Pure Global AI
NCT06044441Not yet recruiting

Evaluation and Implementation Preparation of a Proactive Palliative Care Model (ENABLE-SG)

ENABLE-SG (Educate, Nurture, Advise, Before Life Ends for Singapore) as a Proactive Palliative Care Model: Evaluation and Implementation Preparation
National Cancer Centre, SingaporeClinicalTrials.govbehavioral
Study focus
Disease/Condition
Neoplasms
Drug/Device/Intervention
ENABLE-SG model
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
National Cancer Centre, Singapore
Location
Singapore, Singapore
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Jun 01, 2026
Enrollment
715 participants
Primary outcome

Health-related quality of life of patients with advanced cancer

Summary

The current interdisciplinary specialist palliative care model focuses on supporting patients
 with advanced cancer who have complex problems in the last weeks of life. Consequently,
 palliative care is often provided late and in response to uncontrolled symptoms during
 crises. Palliative care models should shift from this reactionary illness-stress paradigm to
 a proactive health-wellness approach that is integrated early in the patient's disease
 trajectory.
 
 A proactive early palliative care telehealth model, ENABLE (Educate, Nurture, Advise, Before
 Life Ends), was developed in the U.S. to coach patients with advanced cancers and their
 family caregivers on how to cope effectively with serious illness. By empowering individuals
 early before acute distress and symptoms occur, patients and families can better mitigate and
 avoid crises. Building on positive health outcomes demonstrated by the ENABLE model in the
 U.S., the study team has successfully pilot-tested a culturally adapted ENABLE-SG model in
 Singapore. This study seeks to test the effectiveness of this ENABLE-SG model among patients
 with recently diagnosed advanced cancer and their caregivers while simultaneously collecting
 data on real-world implementation.

ICD-10 classifications
NeoplasmsIn situ neoplasmsPersonal history of other neoplasmsBenign neoplasmsMalignant neoplasms
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06044441
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06044441 through Pure Global AI's free database. This phase not specified trial is sponsored by National Cancer Centre, Singapore and is currently Not yet recruiting. The study focuses on Neoplasms. Target enrollment is 715 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.